The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection

Transplantation

Volumn 59, Issue 9, 1995, Pages 1280-1285

  van Saase, Jan L C M ^a,b   van der Woude, Fokko J ^a,c   Thorogood, Jane ^a,c,d   Hollander, Adrianus A M J ^a,c   van Es, Leendert A ^a,c   Weening, Jan J ^c,e   van Bockel, J Hajo ^a,c   Bruijn, Jan Anthonie ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b St Clara Hospital   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d Wellcome Research Foundation   (United Kingdom)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA DR ANTIGEN; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CADAVER KIDNEY; FEMALE; GRAFT SURVIVAL; HISTOINCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERSTITIUM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BLOOD VESSEL; KIDNEY ISCHEMIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; PROGNOSIS; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029065678     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199505000-00010     Document Type: Article

References (34)

1. Gilks WR, Gore SM, Bradley BA. Renal transplant rejection. Transient immunodominance of HLA mismatches. Transplantation 1990; 50: 141.
2. Thorogood J, Persijn GG, Schreuder GMT, et al. The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation 1990; 50: 146.
3. Hall BM, Tiller DJ, Hardie I, et al. Comparison of three immu nosuppressive regimens in cadaveric renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 1988; 318: 1499.
4. Montagnino G, Colturi C, Tarantino A, et al. The impact of azathioprine and cyclosporine on long-term function in kidney transplantation. Transplantation 1991; 51: 772.
5. Gjertson DW, Terasaki PI, Takemoto S, Mikey MR. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med 1991; 324: 1032.
6. Schweitzer EJ, Matas AJ, Gillingham KJ, et al. Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 1991; 214: 679.
7. Venkateswara Rao K, Andersen RC. Long-term results and com plications in renal transplant recipients. Observations in the second decade. Transplantation 1988; 45: 45.
8. Tilney NL, Whitley D, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection-an undefined conundrum. Transplantation 1991; 52: 389.
9. Paul LC, Fellstrom B. Chronic rejection of the heart and the kidney-have rational treatment options emerged? Transplantation 1992; 53: 1169.
10. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ. Studies on morphological outcome of cyclosporine-associ-ated arteriolopathy after discontinuation of cyclosporine in renal allografts. Clin Nephrol 1992; 38: 1.
11. Mihatsch MJ, Ryffel B, Gudat F. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy. Transplant Proc 1993; 25: 2031.
12. Isoniemi HM, Krogerus L, von Willebrand E, Taskinen E, Ahonen J, Hayry P. Histopathological findings in well-func-tioning, long-term renal allografts. Kidney Int 1992; 41: 155.
13. Kootte AMM. Monitoring and management of renal transplant patients. Thesis, Leiden, 1989.
14. Hoitsma AJ, Reekers P, Kreeftenberg JG, Van Lier HJJ, Capel PJA, Koene RAP. Treatment of acute rejection of renal allografts with rabbit antithymocyte globulin. Transplantation 1982; 33: 12.
15. Solez K, Axelsen RA, Benediktsson H, et al. International stan-dardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
16. Salmela KT, von Willebrand EO, Kyllonen LEJ, et al. Acute vascular rejection in renal transplantation-diagnosis and outcome. Transplantation 1992; 54: 858.
17. Gardner MJ, Altman DG. Statistics with confidence. Belfast: The University Press, 1989: 20.
18. Egret Reference Manual. Washington, Statistical and Epidemi ological Research Corp. and Cytel Software Corp., 1990.
19. Isoniemi HM, Ahonen AJ, Tikkanen MJ, et al. Long-term con sequences of different immunosuppressive regimens for renal allografts. Transplantation 1993; 55: 494.
20. Lindholm A, Welsh M, Rutzky L, Kahan BD. The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss. Transplantation 1993; 55: 985.
21. Almond PS, Matas A, Gillingham A, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
22. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
23. Nicol D, MacDonald AS, Lawen J, Belitsky P. Early prediction of renal allograft loss beyond one year. Transplant Int 1993; 6: 153.
24. Yilmaz S, Hayry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 1993; 56: 1153.
25. Solez K, Racusen LC, Marcussen N, et al. Morphology of isch emic acute renal failure, function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 1058.
26. Banfi G, Imbasciati E, Tarantino A, Ponticelli C. Prognostic value of renal biopsy in acute rejection of kidney transplantation. Nephron 1981; 28: 222.
27. Porter KA. Morphological aspects of renal homograft rejection. Br Med Bull 1965; 21: 171.
28. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russel PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111.
29. Paul LC, Claas FHJ, Van Es LA, Kalff MW, De Graeff J. Accel erated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med 1979; 300: 1258.
30. Paul LC, Van Es LA, Van Rood JJ, Van Leeuwen A, Brutel de la Riviere G, De Graeff J. Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts. Transplantation 1979; 27: 175.
31. Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J. The vas cular endothelial cell antigen system. Transplantation 1985; 39: 286.
32. Yard BA, Spruyt-Gerritse M, Claas F, et al. The clinical signif icance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation 1993; 55: 1287.
33. Miltenburg AMM, Meyer-Paape ME, Weening JJ, Daha MR, van Es LA, van der Woude FJ. Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation. Transplantation 1989; 48: 681.
34. Kiley DJ, Lam CS, Poliak R. A study of treatment compliance following kidney transplantation. Transplantation 1993; 55: 51.